Adents: Online Demo Platform

For Cloud-based pharmaceutical serialization, this demo tool allows a “test drive” of Level 4 serialization via Adents Prodigi.

For Cloud-based pharmaceutical serialization, this demo tool allows a “test drive” of Level 4 serialization via Adents Prodigi.
For Cloud-based pharmaceutical serialization, this demo tool allows a “test drive” of Level 4 serialization via Adents Prodigi.

Adents, a provider of serialization and track-and-trace solutions, is launching an online demonstration tool showcasing Adents Prodigi, a Cloud traceability solution that centrally manages pharmaceutical serialization regulatory requirements across a comprehensive set of production and supply chain scenarios. The new, free tool can be accessed by current and prospective Adents customers here.

The demo tool amounts to a test drive of Adents’ signature enterprise level (Level 4) serialization. Visitors can experience various functionalities to discover ways in which Adents Prodigi may benefit their business. The demo tool provides both insight and transparency, adding tangibility to the complex, multi-faceted track-and-trace arena.

The demo tool works in an easy-to-use “if/then” setup. Users can build and add manufacturing facilities, “work” with hypothetical trading partners, add or subtract regulations and target markets, and explore other situational factors that showcase Adents Prodigi’s ability to handle an array of supply chain scenarios. The demo also allows users to see how Adents Prodigi ties unit levels to bundles and pallets per the industry standard parent-child relationship.

Adents Prodigi says it entered the market as the onlyCloud traceability solution that can centrally manage regulatory requirements mandated in the pharmaceutical industry, connect multiple trading partners, and allow pharmaceutical companies and CMOs to benefit from the massive amounts of data generated during the serialization and track-and-trace process.

Adents Prodigi opens up new horizons beyond regulatory compliance, in terms of data analysis (including Microsoft Power BI), machine learning tools, or additional capabilities through existing in-house or third-party solutions.

Companies in this article
More in Pharmaceutical